BlackRock Fund Advisors’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$319K Buy
104,579
+7,228
+7% +$22K ﹤0.01% 3320
2016
Q3
$265K Buy
97,351
+17,654
+22% +$48.1K ﹤0.01% 3362
2016
Q2
$228K Sell
79,697
-791,043
-91% -$2.26M ﹤0.01% 3406
2016
Q1
$2.63M Buy
870,740
+381
+0% +$1.15K ﹤0.01% 2996
2015
Q4
$3.02M Buy
870,359
+27,802
+3% +$96.5K ﹤0.01% 3039
2015
Q3
$3.19M Sell
842,557
-10,041
-1% -$38K ﹤0.01% 2997
2015
Q2
$4.86M Buy
852,598
+776,018
+1,013% +$4.42M ﹤0.01% 2938
2015
Q1
$446K Sell
76,580
-5,184
-6% -$30.2K ﹤0.01% 3287
2014
Q4
$464K Buy
81,764
+5,832
+8% +$33.1K ﹤0.01% 3280
2014
Q3
$311K Sell
75,932
-5,512
-7% -$22.6K ﹤0.01% 3316
2014
Q2
$371K Sell
81,444
-652,125
-89% -$2.97M ﹤0.01% 3273
2014
Q1
$3.48M Buy
733,569
+29,764
+4% +$141K ﹤0.01% 3008
2013
Q4
$3.31M Sell
703,805
-279,943
-28% -$1.32M ﹤0.01% 3028
2013
Q3
$3.92M Buy
983,748
+93,926
+11% +$375K ﹤0.01% 2957
2013
Q2
$3.17M Buy
+889,822
New +$3.17M ﹤0.01% 2958